Bengaluru-based 4baseCare has signed a Memorandum of Understanding with the Government of Maharashtra to set up a Centre of Excellence for Precision Oncology, aiming to integrate genomic-driven cancer care and AI-powered tools into the state’s public healthcare system.
Glimpse:
The MoU was formalized during the PULSE 2026 healthcare and medical education summit in Mumbai. Under the agreement, 4baseCare will deploy its OncoTwin AI platform to help oncologists make data-driven treatment decisions by mapping patients’ genomic and clinical profiles against real-world outcomes. The centre will focus on building clinico-genomic datasets and providing access to advanced diagnostics using Next Generation Sequencing (NGS) technology.
4baseCare has entered into a Memorandum of Understanding with the Government of Maharashtra to establish a Centre of Excellence dedicated to precision oncology. This partnership seeks to bring genomic based cancer care into government healthcare institutions across the state, making personalized and data-driven treatment more accessible to a larger population.
The agreement was signed during PULSE 2026, a major healthcare and medical education summit held in Mumbai. As part of the collaboration, 4baseCare will introduce its OncoTwin platform an artificial intelligence based tool that assists oncologists by comparing a patient’s genomic and clinical data with large real-world outcomes datasets. This helps generate actionable insights for more evidence-based treatment planning. The OncoTwin platform was previously selected for the MSK iHub programme at Memorial Sloan Kettering Cancer Center in New York.
The proposed Centre of Excellence will emphasize the creation of clinico-genomic datasets and facilitate access to advanced cancer diagnostics. It will be equipped with Next Generation Sequencing technology to enable detailed genomic profiling of cancer patients. This infrastructure is expected to allow clinicians to design treatment strategies tailored to each patient’s individual genetic profile, moving away from one size fits all approaches.
The initiative is designed to support oncologists working in public healthcare facilities throughout Maharashtra by providing them with modern tools and insights backed by robust data. It represents a significant step toward embedding precision medicine practices within the state’s public health system.
“This MoU marks an important step towards creating more effective and personalized cancer treatment approaches. We aim to integrate genomic insights into routine cancer care, enabling oncologists to make more informed, evidence-based treatment decisions.”
By
HB Team
Related News
